MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Characteristic Parkinsonism Questionnaire for the Discrimination of Parkinson’s Disease Dementia from Vascular Dementia

PY. Chiu (Changhua, Taiwan)

Meeting: 2019 International Congress

Abstract Number: 1182

Keywords: Dementia, Parkinsonism, Scales

Session Information

Date: Tuesday, September 24, 2019

Session Title: Rating Scales

Session Time: 1:45pm-3:15pm

Location: Les Muses Terrace, Level 3

Objective: We have designed a characteristic 8-item parkinsonism questionnaire for the screening of motor dysfunction due to Lewy body dementia (LBD). We aim to test the effectiveness for the discrimination of motor dysfunction due to Parkinson’s disease dementia (PDD) from vascular dementia (VaD).

Background: Motor dysfunction is the striking feature for both Parkinson’s disease (PD) and cerebral vascular disease (CVD). However, detailed information of motor symptoms for the discrimination of the two diseases is difficult to be acquired.

Method: This study is a retrospective analysis of the project History-based Artificial Intelligent Clinical Dementia Diagnostic System (HAICDDS). A consecutive series of patients with PDD or VaD were analyzed and compared. In their demographical, clinical, neuropsychological, motor, and neuroimaging characteristics.

Results: A total of 743 participants were analyzed, included 218 PDD and 525 VaD. Compared with VaD, PDD showed higher frequency in the first 6 parkinsonism symptoms of the questionnaire (all p < 0.001) and the last symptom (monotonic and hypotonic speech, p = 0.037). However, the 7th symptom (easily falling in the early stage, p = 0.309) was not different between two groups. A cut-off score of 2/3 of total score was suggested for the discrimination of PDD from VaD (sensitivity 0.858; specificity 0.625; AUC 0.809). Whereas, if the 7th and 8th symptoms were replaced with questions regarding the history of cerebrovascular disease (CVD) and the temporal relationship of dementia and CVD, a cut-off score of 2/3 of newer total score was found better for the discrimination of PDD from VaD (sensitivity 0.835; specificity 0.855; AUC 0.923).

Conclusion: This study revealed that a simple characteristic parkinsonism questionnaire was clinically effective for the discrimination PDD from VaD. It deserves attention that a relative high prevalence (37.5%) of LBD like motor dysfunction were found in VaD patients which might rise the possibility of mixed pathologies in these patients.

References: Dahodwala, N., Siderowf, A., Baumgarten, M., Abrams, A., & Karlawish, J. (2012). Screening questionnaires for parkinsonism: a systematic review. Parkinsonism & related disorders, 18(3), 216-224.

To cite this abstract in AMA style:

PY. Chiu. Characteristic Parkinsonism Questionnaire for the Discrimination of Parkinson’s Disease Dementia from Vascular Dementia [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/characteristic-parkinsonism-questionnaire-for-the-discrimination-of-parkinsons-disease-dementia-from-vascular-dementia/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/characteristic-parkinsonism-questionnaire-for-the-discrimination-of-parkinsons-disease-dementia-from-vascular-dementia/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley